• Product nameAnti-SH2D1A/SAP antibody
    See all SH2D1A/SAP primary antibodies
  • Description
    Goat polyclonal to SH2D1A/SAP
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Pig, Macaque monkey
  • Immunogen

    Synthetic peptide:


    , corresponding to internal sequence amino acids 99-112 of Human SH2D1A/SAP

  • Positive control
    • Human Lymph Node lysate.


  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • Storage bufferPreservative: 0.02% Sodium Azide
    Constituents: 0.5% BSA, Tris saline, pH 7.3
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • Purification notesPurified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas


Our Abpromise guarantee covers the use of ab50422 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 0.2 - 0.6 µg/ml. Detects a band of approximately 16 kDa (predicted molecular weight: 14 kDa).


  • FunctionInhibitor of the SLAM self-association. Acts by blocking recruitment of the SH2-domain-containing signal-transduction molecule SHP-2 to a docking site in the SLAM cytoplasmic region. Mediates interaction between FYN and SLAMF1. May also regulate the activity of the neurotrophin receptors NTRK1, NTRK2 and NTRK3.
  • Tissue specificityExpressed at a high level in thymus and lung, with a lower level of expression in spleen and liver. Expressed in peripheral blood leukocytes, including T lymphocytes. Tends to be expressed at lower levels in peripheral blood leukocytes in patients with rheumatoid arthritis.
  • Involvement in diseaseDefects in SH2D1A are a cause of lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240]; also known as X-linked lymphoproliferative disease (XLPD) or Duncan disease. XLP is a rare immunodeficiency characterized by extreme susceptibility to infection with Epstein-Barr virus (EBV). Symptoms include severe or fatal mononucleosis, acquired hypogammaglobulinemia, pancytopenia and malignant lymphoma.
  • Sequence similaritiesContains 1 SH2 domain.
  • Cellular localizationCytoplasm.
  • Information by UniProt
  • Database links
  • Alternative names
    • DSHP antibody
    • Duncan disease SH2 protein antibody
    • Duncan disease SH2-protein antibody
    • EBVS antibody
    • IMD5 antibody
    • LYP antibody
    • MTCP1 antibody
    • SAP antibody
    • SAP/SH2D1A antibody
    • SH2 domain containing 1A antibody
    • SH2 domain protein 1A antibody
    • SH2 domain-containing protein 1A antibody
    • SH21A_HUMAN antibody
    • SH2D1A antibody
    • Signaling lymphocyte activation molecule associated protein antibody
    • Signaling lymphocytic activation molecule-associated protein antibody
    • SLAM associated protein antibody
    • SLAM associated protein/SH2 domain protein 1A antibody
    • SLAM-associated protein antibody
    • T cell signal transduction molecule SAP antibody
    • T-cell signal transduction molecule SAP antibody
    • XLP antibody
    • XLPD antibody
    see all

Anti-SH2D1A/SAP antibody images

References for Anti-SH2D1A/SAP antibody (ab50422)

ab50422 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab50422.
Please use the links above to contact us or submit feedback about this product.